Tumor Immunology and Immunotherapy

Tumor Immunology and Immunotherapy

Author: Robert C. Rees

Publisher: Oxford University Press, USA

ISBN: 9780199676866

Category: Medical

Page: 442

View: 679

Download BOOK »

Patients are beginning to benefit from antibody based, cellular and vaccine approaches that are effective against genetically diverse and therapy-resistance cancers. BCG immunotherapy is now being used as a first line treatment for human bladder cancer and the introduction of prophylactic vaccination against Hepatitis B and HPV cancers is starting to show positive results. Following recent FDA approval for a vaccination against prostate cancer, and optimistic results in clinical trials for a vaccine targeting cancer antigens in lung cancer, cancer immunotherapy is now significantly impacting patient clinical management. Tumor Immunology and Immunotherapy provides an up-to-date and comprehensive account of cancer immunity and immunotherapy. It discusses our adaptive and innate immunity to cancer, the mechanisms underpinning our immune response, current approaches to cancer immunotherapy, and how tumour and host responses can circumvent effective anti-cancer immunity. The book examines recent results, publications and current areas of interest including 'immune editing' and the specific issues that are affecting the research and development of vaccines, providing insight into how these problems may be overcome, as viewed by world leaders in the field. Tumor Immunology and Immunotherapy will appeal to clinicians working in oncology and cancer immunotherapy, and research scientists including PhD and masters students, post-doctoral researchers and senior investigators.
Tumor Immunology and Immunotherapy
Language: en
Pages: 442
Authors: Robert C. Rees
Categories: Medical
Type: BOOK - Published: 2014-05-20 - Publisher: Oxford University Press, USA

Patients are beginning to benefit from antibody based, cellular and vaccine approaches that are effective against genetically diverse and therapy-resistance cancers. BCG immunotherapy is now being used as a first line treatment for human bladder cancer and the introduction of prophylactic vaccination against Hepatitis B and HPV cancers is starting
Cancer Immunology
Language: en
Pages: 802
Authors: Nima Rezaei
Categories: Medical
Type: BOOK - Published: 2020-01-03 - Publisher: Springer Nature

This book focusing on the immunopathology of cancers is published as part of the three-volume Springer series Cancer Immunology, which aims to provide an up-to-date, clinically relevant review of cancer immunology and immunotherapy. Readers will find detailed descriptions of the interactions between cancerous cells and various components of the innate
Cancer Immunology and Immunotherapy
Language: en
Pages: 306
Authors: Glenn Dranoff
Categories: Medical
Type: BOOK - Published: 2011-04-11 - Publisher: Springer Science & Business Media

The interplay between tumors and their immunologic microenvironment is complex, difficult to decipher, but its understanding is of seminal importance for the development of novel prognostic markers and therapeutic strategies. The present review discusses tumor-immune interactions in several human cancers that illustrate various aspects of this complexity and proposes an
Cancer Immunology
Language: en
Pages: 488
Authors: Nima Rezaei
Categories: Medical
Type: BOOK - Published: 2015-04-24 - Publisher: Springer

Cancer Immunology is intended as an up-to-date, clinically relevant review of cancer immunology and immunotherapy. This volume focuses on the immunopathology and immunotherapy of organ cancers in detail. It clearly explains their immunology and describes novel immunotherapy for specific cancers, including pediatric solid tumors, hematologic malignancies, gastrointestinal tumors, skin cancers,
Advances in Tumor Immunology and Immunotherapy
Language: en
Pages: 371
Authors: Joseph D. Rosenblatt, Eckhard R. Podack, Glen N. Barber, Augusto Ochoa
Categories: Medical
Type: BOOK - Published: 2013-10-25 - Publisher: Springer Science & Business Media

Recent advances in understanding of fundamental immunology have created new insights into the dynamic interactions between tumors and the immune system. This includes new understanding of T- and B-cell interaction, immune inhibitory mechanisms including the biology of T regulatory cells, myeloid suppressor cells, and dendritic cell subsets. Enhanced understanding of